CLBBB n=42 Non-CLBBB n=168
P-value
Age, years 65.3±8.7 64.3±9.5 0.557
Female, n(%) 17(40.5) 67(39.9) 0.944
BMI, kg/m2 23.7±2.8 23.8±3.1 0.910
Persistent AF, n(%) 18(42.9) 66(39.3) 0.805
AF duration, years [M(P25, P75)] 1.1(0.2-5.2) 1.1(0.1-5.0) 0.666
ALT, U/L [M(P25, P75)] 21.5(17.0-31.8) 21.0(14.0-31.0) 0.441
Cr, umol/L [M(P25, P75)] 78.7(70.6-87.6) 77.8(65.4-89.8) 0.747
Hemoglobin, g/L 140.6±17.4 142.5±18.2 0.549
QRS duration, ms [M(P25, P75)] 157.0(122.0- 200.0) 90.0(68.0-118.0) <0.001
Echocardiography
LAD, mm (\(\overset{\overline{}}{x}\)±s) 39.7±5.1 39.3±5.7 0.711
LVEF, % (\(\overset{\overline{}}{x}\)±s) 50.9±12.9 51.4±12.7 0.793
LVEDD, mm (\(\overset{\overline{}}{x}\)±s) 52.3±5.5 52.3±6.6 0.997
Concomitant disease
Heart failure, n(%) 8(19.0) 32(19.0) 1.000
Coronary artery disease, n(%) 16(38.1) 57(33.9) 0.744
Hypertension, n(%) 20(47.6) 81(48.2) 1.000
Diabetes Mellitus, n(%) 8(19.0) 30(17.9) 1.000
Ischemic stroke, n(%) 2(4.8) 5(3.0) 0.923
COPD, n(%) 3(7.1) 5(3.0) 0.417
Medication
ACEI/ARBs, n (%) 15(35.7) 57(33.9) 0.827
Statins, n (%) 10(23.8) 46(27.4) 0.640
β-blockers, n (%) 17(40.5) 49(29.2) 0.158
CHA2DS2-VASc score 2.3±1.6 2.2±1.5 0.779